Skip to main content
M

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Filings indexed 1,180 across all filing types
Latest filing 2024-10-24 Regulatory Filings
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
Results of Meeting 2 pages 56.4KB
Regulatory Filings
2024-10-24 English
Felix Trial registration update 3 pages 182.8KB
Regulatory Filings
2024-10-23 English
Investor Webinar Invitation 2 pages 140.1KB
Regulatory Filings
2024-10-23 English
Extension of SPP offer 2 pages 225.2KB
Regulatory Filings
2024-10-21 English
Update - Proposed issue of securities - MEM 12 pages 38.1KB
Regulatory Filings
2024-10-21 English
Equine study commences with 12mth commercialisation expected 3 pages 193.4KB
Regulatory Filings
2024-10-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.